Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRIN1 | Q05586 | 6/20 | 0.75 |
| ▸ | GRIN2A | Q12879 | 6/20 | 0.75 |
| ▸ | GRIN2D | O15399 | 5/20 | 0.75 |
| ▸ | GRIN2C | Q14957 | 5/20 | 0.75 |
| ▸ | GRIN2B | Q13224 | 4/20 | 0.75 |
| ▸ | OPRM1 | P35372 | 4/20 | 0.75 |
| ▸ | KCNH2 | Q12809 | 4/20 | 0.75 |
| ▸ | DRD3 | P35462 | 3/20 | 0.75 |
| ▸ | OPRK1 | P41145 | 2/20 | 0.75 |
| ▸ | DRD4 | P21917 | 2/20 | 0.75 |
| ▸ | CACNA1F | O60840 | 1/20 | 0.75 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.75 |
| ▸ | CYP2B6 | P20813 | 1/20 | 0.75 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.75 |
| ▸ | CACNA1D | Q01668 | 1/20 | 0.75 |
| ▸ | CACNA1S | Q13698 | 1/20 | 0.75 |
| ▸ | CACNA1C | Q13936 | 1/20 | 0.75 |
| ▸ | MRGPRX2 | Q96LB1 | 1/20 | 0.75 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.52 |
| ▸ | LMNA | P02545 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Aminopentamide Sulfate SCHEMBL203612 | 0.94 | GRIN1 (0.68) | GRIN1GRIN2AGRIN2DGRIN2CGRIN2B | |
| SCHEMBL6264501 | 0.87 | GRIN1 (0.74) | GRIN1GRIN2AGRIN2DGRIN2CGRIN2B | |
| SCHEMBL11422970 | 0.87 | GRIN1 (0.74) | GRIN1GRIN2AGRIN2DGRIN2CGRIN2B | |
| SCHEMBL22313203 | 0.87 | GRIN1 (0.74) | GRIN1GRIN2AGRIN2DGRIN2CGRIN2B | |
| Levomethadone SCHEMBL8506268 | 0.86 | GRIN1 (1.00) | GRIN1GRIN2AGRIN2DGRIN2CGRIN2B | |
| Methadone SCHEMBL34140 | 0.86 | GRIN1 (1.00) | GRIN1GRIN2AGRIN2DGRIN2CGRIN2B | |
| Esmethadone SCHEMBL24294 | 0.86 | GRIN1 (1.00) | GRIN1GRIN2AGRIN2DGRIN2CGRIN2B | |
| Methadone SCHEMBL17008675 | 0.86 | GRIN1 (1.00) | GRIN1GRIN2AGRIN2DGRIN2CGRIN2B | |
| Levomethadone SCHEMBL147864 | 0.86 | GRIN1 (1.00) | GRIN1GRIN2AGRIN2DGRIN2CGRIN2B | |
| SCHEMBL11804700 | 0.86 | GRIN1 (0.68) | GRIN1GRIN2AGRIN2DGRIN2CGRIN2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 243 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3523325-B1 | INDUCIBLE CASPASES AND METHODS FOR USE | POSEIDA THERAPEUTICS INC (US) | 2025-08-06 | — | — | EP | claimed |
| EP-3801523-B1 | SPLICING MODULATORS | EISAI R&D MAN CO LTD (JP) | 2024-09-11 | — | — | EP | claimed |
| CN-116887804-A | Cleaning composition | 莱雅公司 | 2023-10-13 | — | — | CN | claimed |
| WO-2023126971-A1 | ORAL FILMS OF ANTI-EMETIC DRUGS | LAURUS LABS LIMITED (IN) | 2023-07-06 | — | — | WO | claimed |
| CN-111179416-B | Vascular vector diagram model generation method and device | 北京东方逸腾数码医疗设备技术有限公司 | 2023-04-25 | — | — | CN | claimed |
| WO-2016073991-A2 | EDIBLE CAT TOY | Urban Pet Haus, LLC (US) | 2016-05-12 | — | — | WO | claimed |
| US-9016221-B2 | Surface topographies for non-toxic bioadhesion control | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) | 2015-04-28 | — | — | US | claimed |
| US-20100226943-A1 | SURFACE TOPOGRAPHIES FOR NON-TOXIC BIOADHESION CONTROL | UNIVERSITY OF FLORIDA (US) | 2010-09-09 | — | — | US | claimed |
| CN-101330905-A | Freeze-drying process and products obtained thereby | SCIDOSE LLC (US) | 2008-12-24 | — | — | CN | claimed |
| EP-1954244-A1 | LYOPHILIZATION PROCESS AND PRODUCTS OBTAINED THEREBY | Scidose, Llc (US) | 2008-08-13 | — | — | EP | claimed |
| WO-2007061529-A1 | LYOPHILIZATION PROCESS AND PRODUCTS OBTAINED THEREBY | SCIDOSE LLC. (US) | 2007-05-31 | — | — | WO | claimed |
| US-20070116729-A1 | Lyophilization process and products obtained thereby | SCIDOSE LLC | 2007-05-24 | — | — | US | claimed |
| EP-1273301-B1 | Pharmaceutical preparations based on active ingredients susceptible to illicit administration | ALTERGON SA (CH) | 2006-09-06 | — | — | EP | claimed |
| EP-1273301-A2 | Pharmaceutical preparations based on active ingredients susceptible to illicit administration | ALTERGON S.A. (CH) | 2003-01-08 | — | — | EP | claimed |
| US-20260124217-A1 | COMPOSITIONS OF BIFUNCTIONAL INHIBITORS OF TETRACYCLINE INACTIVATING ENZYMES AND METHODS OF USE THEREOF | WASHINGTON UNIVERSITY (US) | 2026-05-07 | — | — | US | disclosed |
| US-20260097102-A1 | Treatment Of Respiratory Disorders With Arachidonate 15-Lipoxygenase (ALOX15) Inhibitors | REGENERON PHARMA (US) | 2026-04-09 | — | — | US | disclosed |
| US-12472241-B2 | Treatment of respiratory disorders with arachidonate 15-lipoxygenase (ALOX15) inhibitors | REGENERON PHARMACEUTICALS, INC. (US) | 2025-11-18 | — | — | US | disclosed |
| EP-0764169-A2 | DRUG SALTS | DUMEX-ALPHARMA A/S (DK) | 1997-03-26 | — | — | EP | disclosed |
| WO-1995034571-A2 | DRUG SALTS | DUMEX ALPHARMA A/S (DK) | 1995-12-21 | — | — | WO | disclosed |
| US-3896221-A | Anesthetic composition | AMERICAN HOME PRODUCTS CORPORATION, A CORP. OF DE. | 1975-07-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260124217-A1 | COMPOSITIONS OF BIFUNCTIONAL INHIBITORS OF TETRACYCLINE INACTIVATING ENZYMES AND METHODS OF USE THEREOF | TDO2, TKT, COASY | GRIN1 4687/4885GRIN2A 4686/4885GRIN2D 4277/4885 |
| US-20260097102-A1 | Treatment Of Respiratory Disorders With Arachidonate 15-Lipoxygenase (ALOX15) Inhibitors | ALOX15, ALOX15B, ALOX5 | GRIN1 4190/4885GRIN2A 4169/4885GRIN2D 4198/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.